RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cellectar Biosciences - Stock

Cellectar Biosciences ROA 2024

Cellectar Biosciences ROA

-3.15

Ticker

CLRB

ISIN

US15117F5008

WKN

A2NB71

In 2024, Cellectar Biosciences's return on assets (ROA) was -3.15, a 137.45% increase from the -1.32 ROA in the previous year.

Cellectar Biosciences Aktienanalyse

What does Cellectar Biosciences do?

Cellectar Biosciences is a biotechnology company specializing in the development of innovative cancer therapies. It was founded in 2003 and is headquartered in Madison, Wisconsin, USA. The company's mission is to revolutionize cancer treatment by developing therapies with high efficacy. Cellectar Biosciences focuses on research and development in the areas of preclinical development, clinical trials, and product registration. It has expanded its business to include radiation therapy and imaging diagnostics. The company is divided into different divisions for effective work and specialization. It has partnerships with leading players in the biotechnology industry. Overall, Cellectar Biosciences has built an impressive portfolio of products and services to meet the needs of patients and healthcare providers and will continue to play a significant role in the biotechnology industry in the future. Cellectar Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Cellectar Biosciences's Return on Assets (ROA)

Cellectar Biosciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Cellectar Biosciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Cellectar Biosciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Cellectar Biosciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Cellectar Biosciences Stock

What is the Return on Assets (ROA) of Cellectar Biosciences this year?

The Return on Assets (ROA) of Cellectar Biosciences is -3.15 undefined this year.

What was the ROA of Cellectar Biosciences compared to the previous year?

The ROA of Cellectar Biosciences has increased by 137.45% compared to the previous year.

What consequences do high ROA have for investors of Cellectar Biosciences?

A high ROA is advantageous for investors of Cellectar Biosciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Cellectar Biosciences?

A low ROA can be unfavorable for investors of Cellectar Biosciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Cellectar Biosciences affect the company?

An increase in ROA of Cellectar Biosciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Cellectar Biosciences impact the company?

A reduction in the ROA of Cellectar Biosciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Cellectar Biosciences?

Some factors that can influence the ROA of Cellectar Biosciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Cellectar Biosciences important for investors?

The ROA of Cellectar Biosciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Cellectar Biosciences take to improve ROA?

To improve ROA, Cellectar Biosciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Cellectar Biosciences pay?

Over the past 12 months, Cellectar Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cellectar Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cellectar Biosciences?

The current dividend yield of Cellectar Biosciences is .

When does Cellectar Biosciences pay dividends?

Cellectar Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cellectar Biosciences?

Cellectar Biosciences paid dividends every year for the past 0 years.

What is the dividend of Cellectar Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cellectar Biosciences located?

Cellectar Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cellectar Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cellectar Biosciences from 6/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.

When did Cellectar Biosciences pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Cellectar Biosciences in the year 2023?

In the year 2023, Cellectar Biosciences distributed 0 USD as dividends.

In which currency does Cellectar Biosciences pay out the dividend?

The dividends of Cellectar Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cellectar Biosciences

Our stock analysis for Cellectar Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellectar Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.